Immunoproliferative small intestinal disease (IPSID): An overview

  • Shakil Gani Department of Hepatology, BSMMU, Dhaka
  • Mamun Al-Mahtab Department of Hepatology, BSMMU, Dhaka
  • Salimur Rahman Department of Hepatology, BSMMU, Dhaka
Keywords: IPSID

Abstract

Immunoproliferative small intestinal disease (IPSID) is a poorly recognized cause of malabsorption syndrome. IPSID shares clinical, morphologic, and molecular features with mucosa-associated lymphoid tissue (MALT) lymphoma, lymphoplasmacyticlymphoma, and plasma cell neoplasms, which involves mainly the proximal small intestine. It is mostly found in young adults of low socioeconomic class and poor sanitation in developing countries. Early-stage IPSID responds to antibiotics. Most untreated IPSID patients progress to lymphoplasmacytic and immunoblastic lymphoma invading the intestinal wall and mesenteric lymph nodes, and may metastasizeto a distant organ. It may be a major public health issue in developing countries.

International Journal of Hepatology Vol.1(3) 2010 pp.31-35

Downloads

Download data is not yet available.
Abstract
816
Published
2010-11-29
How to Cite
Gani, S., Al-Mahtab, M., & Rahman, S. (2010). Immunoproliferative small intestinal disease (IPSID): An overview. International Journal of Hepatology, 1(3), 31-35. Retrieved from https://www.banglajol.info/index.php/IJH/article/view/6564
Section
Review Articles